Apri (desogestrel and ethinyl estradiol tablets USP) recall: Impurity Out of Spec
Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville…
Why was Apri (desogestrel and ethinyl estradiol tablets USP) recalled?
Failed Impurities/Degradation Specifications: out of specification impurity test results.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot 3805324A Exp. 11/14
- Product
- Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville…
- Recalling firm
- Teva Pharmaceuticals USA
- Quantity
- 1104 blister packs
- Distribution
- Nationwide
- Recall date
- July 23, 2014
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)